The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to ...

A growing pool of studies finds concerning levels of plastic and forever chemicals in our common food items and their ...

President Trump has vowed to impose tariffs on China, Mexico, and Canada. They could make common medicines less affordable.

Kennedy’s potential ascent as HHS secretary brings promise for backers of alternative-health approaches, while skeptics say ...

19,688 cases of the milk overall were recalled, 8,654 of which had an expiry date of 3/3/2025, 7,385 with expiry date 3/4/2025, 1,781 with expiry date 3/6/2025, and 1,868 with expiry date 3/7/2025.

One-third of folks with major depressive disorder experience treatment-resistant depression (TRD), a condition that makes it ...

Last year was a productive and exciting year for Alzheimer’s and dementia research. There were significant advancements in early detection, treatment, and risk management. Here are three significant d ...

Amid a deluge of executive actions, the Trump administration has asked federal health agencies to pause external ...

Dr. Robert M. Califf bid farewell to his role as Commissioner of the U.S. Food and Drug Administration in a reflective post ...

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.

The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...